Clinical Trial Update: Predictive Proteomic Factors of the Response to Concomitant Radiochemotherapy in Esophageal Cancer [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating predictive proteomic factors of response to concomitant radiochemotherapy in esophageal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Snippet

Sponsor: Centre Oscar Lambret | Conditions: Esophageal Cancer | Phase 4 | Status: COMPLETED